retatrutide weight loss studies Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide: The Breakthrough Shot Revolutionizing

Emerging research suggests GLP-1s may directly affect the skin by reducing collagen production, accelerating glycation (which stiffens and weakens collagen fibers), and diminishing hydration levels

Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist

GLP-1RA decreases ectopic, perivascular, and epicardial adipose tissue all known to increase the risk of cardiovascular disease [17]

Given that retatrutide works through similar mechanisms but with additional pathways, there is scientific rationale to expect comparable or even enhanced benefits

What if my GLP-1 injection isnt effective enough